120 related articles for article (PubMed ID: 3162284)
1. Preoperative serum CA-125 levels in patients with surgical stage I invasive ovarian adenocarcinoma.
Mann WJ; Patsner B; Cohen H; Loesch M
J Natl Cancer Inst; 1988 Apr; 80(3):208-9. PubMed ID: 3162284
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum CA-125 levels in early stage ovarian cancer.
Patsner B
Eur J Gynaecol Oncol; 1990; 11(5):319-21. PubMed ID: 2097148
[TBL] [Abstract][Full Text] [Related]
3. Elevation of multiple serum markers in patients with stage I ovarian cancer.
Woolas RP; Xu FJ; Jacobs IJ; Yu YH; Daly L; Berchuck A; Soper JT; Clarke-Pearson DL; Oram DH; Bast RC
J Natl Cancer Inst; 1993 Nov; 85(21):1748-51. PubMed ID: 8411259
[TBL] [Abstract][Full Text] [Related]
4. Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
Bast RC; Knauf S; Epenetos A; Dhokia B; Daly L; Tanner M; Soper J; Creasman W; Gall S; Knapp RC
Cancer; 1991 Oct; 68(8):1758-63. PubMed ID: 1913520
[TBL] [Abstract][Full Text] [Related]
5. Serum CA 125 in epithelial ovarian cancer. A longitudinal study.
Brioschi PA; Irion O; Bischof P; Bader M; Forni M; Krauer F
Br J Obstet Gynaecol; 1987 Mar; 94(3):196-201. PubMed ID: 3471273
[TBL] [Abstract][Full Text] [Related]
6. CA 15-3 serum levels in ovarian cancer.
Scambia G; Benedetti Panici P; Baiocchi G; Perrone L; Greggi S; Di Roberto P; Mancuso S
Oncology; 1988; 45(3):263-7. PubMed ID: 3163419
[TBL] [Abstract][Full Text] [Related]
7. Tumor antigen NB/70K and CA 125 levels in the blood of preoperative ovarian cancer patients and controls: a preliminary report of the use of the NB12123 and CA 125 radioimmunoassays alone and in combination.
Knauf S; Bast RC
Int J Biol Markers; 1988; 3(2):75-81. PubMed ID: 3243980
[TBL] [Abstract][Full Text] [Related]
8. [Experiences with the tumor markers Ca 125 and plasma ribonuclease in ovarian cancer].
Lücke R; Benz R; Kraus H
Geburtshilfe Frauenheilkd; 1987 Dec; 47(12):846-9. PubMed ID: 3481339
[TBL] [Abstract][Full Text] [Related]
9. Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?
Patsner B; Orr JW; Mann WJ; Taylor PT; Partridge E; Allmen T
Gynecol Oncol; 1990 Jun; 37(3):319-22. PubMed ID: 2190870
[TBL] [Abstract][Full Text] [Related]
10. An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma.
Zurawski VR; Knapp RC; Einhorn N; Kenemans P; Mortel R; Ohmi K; Bast RC; Ritts RE; Malkasian G
Gynecol Oncol; 1988 May; 30(1):7-14. PubMed ID: 2452773
[TBL] [Abstract][Full Text] [Related]
11. Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinoma.
Patsner B; Mann WJ; Vissicchio M; Loesch M
Gynecol Oncol; 1988 May; 30(1):98-103. PubMed ID: 2452774
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
Kobayashi H; Terao T; Kawashima Y
J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
[TBL] [Abstract][Full Text] [Related]
13. [Clinical usefulness of the combination assay of CA 125, SLX, and CA 72-4 in patients with ovarian cancer].
Kobayashi H; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1731-5. PubMed ID: 2574209
[TBL] [Abstract][Full Text] [Related]
14. Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumour recurrence.
Schilthuis MS; Aalders JG; Bouma J; Kooi H; Fleuren GJ; Willemse PH; De Bruijn HW
Br J Obstet Gynaecol; 1987 Mar; 94(3):202-7. PubMed ID: 3471274
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma.
Patsner B; Mann WJ; Cohen H; Loesch M
Am J Obstet Gynecol; 1988 Feb; 158(2):399-402. PubMed ID: 2449079
[TBL] [Abstract][Full Text] [Related]
16. A proteomics panel for predicting optimal primary cytoreduction in stage III/IV ovarian cancer.
Risum S; Høgdall E; Engelholm SA; Fung E; Lomas L; Yip C; Petri AL; Nedergaard L; Lundvall L; Høgdall C
Int J Gynecol Cancer; 2009 Dec; 19(9):1535-8. PubMed ID: 19955932
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum CA-125 levels in borderline tumors of the ovary.
Rice LW; Lage JM; Berkowitz RS; Goodman A; Muto MG; Knapp RC; Bell DA
Gynecol Oncol; 1992 Aug; 46(2):226-9. PubMed ID: 1500026
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
Kivinen S; Kuoppala T; Leppilampi M; Vuori J; Kauppila A
Obstet Gynecol; 1986 Apr; 67(4):468-72. PubMed ID: 3008051
[TBL] [Abstract][Full Text] [Related]
19. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of the recurrence of epithelial ovarian cancer with the tumor marker CA 125].
Sevelda P; Wagner G
Wien Klin Wochenschr; 1987 Nov; 99(21):768-70. PubMed ID: 3480655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
